Leif Johansson - Articles and news items


AstraZeneca Board rejects Pfizer’s final proposal

Industry news / 20 May 2014 / AstraZeneca

The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal, comprising £24.76 in cash (45%) and 1.747 Pfizer shares (55%) per AstraZeneca share, representing a value of £55.00 per AstraZeneca share (based on the closing price of Pfizer shares on 16 May 2014…


AstraZeneca proposes appointment of Ann Cairns as Non-Executive Director

Industry news / 20 March 2014 / AstraZeneca

AstraZeneca announced that Ann Cairns will be proposed to shareholders for election as a Non-Executive Director at the Company’s Annual General Meeting on 24 April 2014…


Marc Dunoyer appointed Chief Financial Officer of AstraZeneca

Industry news / 31 October 2013 / AstraZeneca

“Following a thorough and extensive search it became clear that Marc possessed the rare blend of financial, business and science experience…”

Pascal Soriot, AstraZeneca's new Chief Executive Officer

Pascal Soriot appointed Chief Executive Officer of AstraZeneca

Industry news, News / 28 August 2012 / AstraZeneca

AstraZeneca announced that Pascal Soriot has been appointed as the company’s Chief Executive Officer…


AstraZeneca announces Non-Executive changes, retirement of Chairman and appointment of successor

Industry news, News / 1 March 2012 / AstraZeneca

Leif Johansson proposed to shareholders for election as a Non-Executive Director…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...